Weaker antibody response to first COVID-19 vaccine dose found in long-term care residents
MONTREAL, March 25, 2021 (GLOBE NEWSWIRE) -- A single dose of the Pfizer-BioNTech COVID-19 vaccine produces a much weaker antibody...
News
Zogenix to Participate in the Stifel 3rd Annual CNS Day
EMERYVILLE, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease...
Ayala Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Business Update
- Completed $25 Million Strategic Financing; Extending Cash Runway into 2023 - Accelerated Development of AL102 Desmoid Tumor Program into...
Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital
Funding to advance platform and portfolio of intranasal products that protect against a broad range of respiratory viruses, including influenza...
Shockwave Appoints Sara Toyloy to Board of Directors
SANTA CLARA, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of...
Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates
WAKIX®(pitolisant) Total Revenue of $160 Million for Full-Year 2020; $56 Million for Fourth Quarter 2020 Clinical Utility of WAKIX was...
Intellia Therapeutics Presents New Data on Expanded Cell Engineering Capabilities Utilizing Base Editors
CAMBRIDGE, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA) will present the first preclinical data set on...
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Patient enrollment and dosing in the Phase 1/2 clinical trial of BDTX-189 continue to track in line with projections at...
PureK Holdings Corp. ‘TRUBAR’ Plant-Based Nutrition Brand to Expand Into Canada
VANCOUVER, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) -- PureK Holdings Corp. (the "Company" or "PureK") (TSX Venture: PKAN) is...
Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
Refreshed board to bring fresh perspectives, relevant expertise and diverse experienceNEW YORK and CLEVELAND, March 25, 2021 (GLOBE NEWSWIRE) --...
Solid Biosciences to Participate at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day
CAMBRIDGE, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing...
Avicanna to Participate in Benzinga Biotech Small Cap Conference and the Virtual Life Sciences Investor Forum Both Taking Place on Thursday March 25th
TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a...
Venus Concept Announces Global Brand Ambassador Partnership with Tennis Champion and Entrepreneur Venus Williams
TORONTO, March 25, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Otonomy Initiates Phase 2 Clinical Trial of OTO-313 in Tinnitus
Phase 2 study design based on successful Phase 1/2 trial including use of Tinnitus Functional Index (TFI) responder analysis for...
Aurora Spine Receives FDA 510(K) Clearance for Its Proprietary APOLLO Anterior Cervical Plate
CARLSBAD, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),...
Orpea SA: Pre Stabilisation Notice
PARIS, March 25, 2021 (GLOBE NEWSWIRE) -- ORPEA SA Pre Stabilisation Notice HSBC (contact: 'synd manager'; telephone: +44 207 992...
Aleafia Health Reports 2020 Year End Results, Record Quarterly Revenue
233% increase in Q/Q cannabis net revenue$4.3 million positive adjusted EBITDA in Q4 202042% and 501% increase in Q/Q medical...
Zentalis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update
Initiated multiple early-stage clinical trials evaluating its oral SERD, ZN-c5, WEE1 inhibitor, ZN-c3 and BCL-2 inhibitor, ZN-d5 Announced strategic collaboration...
Immunocore Provides Business Update and Reports Full Year 2020 Financial Results
Immunocore Provides Business Update and Reports Full Year 2020 Financial Results Breakthrough Therapy Designation granted by the FDA for tebentafusp...
VBL Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Conference Call and Webcast at 8:30 a.m. EDT Today Continued progress in OVAL Phase 3 registration enabling study investigating VB-111...